- Home
- ADSE vs ORGO Comparison
ADSE vs ORGO Comparison
Compare ADSE & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADSE
- ORGO
- Stock Information
- Founded
- ADSE 1980
- ORGO 1985
- Country
- ADSE Ireland
- ORGO United States
- Employees
- ADSE N/A
- ORGO N/A
- Industry
- ADSE Industrial Specialties
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- ADSE Consumer Discretionary
- ORGO Health Care
- Exchange
- ADSE Nasdaq
- ORGO Nasdaq
- Market Cap
- ADSE 777.7M
- ORGO 665.8M
- IPO Year
- ADSE N/A
- ORGO N/A
- Fundamental
- Price
- ADSE $12.70
- ORGO $4.22
- Analyst Decision
- ADSE Hold
- ORGO Buy
- Analyst Count
- ADSE 1
- ORGO 2
- Target Price
- ADSE $14.00
- ORGO $5.50
- AVG Volume (30 Days)
- ADSE 107.4K
- ORGO 1.4M
- Earning Date
- ADSE 04-29-2025
- ORGO 05-08-2025
- Dividend Yield
- ADSE N/A
- ORGO N/A
- EPS Growth
- ADSE N/A
- ORGO N/A
- EPS
- ADSE N/A
- ORGO N/A
- Revenue
- ADSE $158,974,606.00
- ORGO $482,043,000.00
- Revenue This Year
- ADSE $107.27
- ORGO $3.31
- Revenue Next Year
- ADSE $57.96
- ORGO $12.50
- P/E Ratio
- ADSE N/A
- ORGO N/A
- Revenue Growth
- ADSE 168.42
- ORGO 11.29
- 52 Week Low
- ADSE $10.17
- ORGO $2.17
- 52 Week High
- ADSE $16.35
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- ADSE 45.22
- ORGO 47.71
- Support Level
- ADSE $10.63
- ORGO $3.57
- Resistance Level
- ADSE $12.76
- ORGO $4.38
- Average True Range (ATR)
- ADSE 1.07
- ORGO 0.34
- MACD
- ADSE -0.03
- ORGO -0.00
- Stochastic Oscillator
- ADSE 48.66
- ORGO 75.27
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services which enable the customer to control and manage the system. Geographically, it derives a majority of its revenue from Europe.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.